Cargando…

Identification of the Novel Oncogenic Role of SAAL1 and Its Therapeutic Potential in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide, affecting over 700,000 people per year. The treatment effect in advanced HCC is still disappointing and prognosis of advanced HCC remains poor. Hence, to find more effective therapeutic targets to improve the treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Pei-Yi, Tung, Shiao-Lin, Tsai, Kuo-Wang, Shen, Fang-Ping, Chan, Shih-Hsuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408781/ https://www.ncbi.nlm.nih.gov/pubmed/32650537 http://dx.doi.org/10.3390/cancers12071843

Ejemplares similares

SAAL1, a novel oncogene, is associated with prognosis and immunotherapy in multiple types of cancer
por: Yang, Wei, et al.
Publicado: (2022)

Bisphenol A: vom Saal and Hughes Respond
por: vom Saal, Frederick S., et al.
Publicado: (2006)

A Novel lncRNA SAAL Suppresses IAV Replication by Promoting Innate Responses
por: Liu, Qingzheng, et al.
Publicado: (2022)

Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
por: Chu, Pei-Yi, et al.
Publicado: (2021)

The silencing of SAAL1 suppresses pneumonia progression via modulating the NLR signaling pathway
por: Chen, Wei, et al.
Publicado: (2022)

The effects of the prognostic biomarker SAAL1 on cancer growth and its association with the immune microenvironment in lung adenocarcinoma
por: Tong, Song, et al.
Publicado: (2023)

Pauli Obituary Collection: "Einweihung eines 'Pauli-Saals' im CERN", in: Tages-Anzeiger, article
por: [unknown]
Publicado: (2004)

Elmar Peschke (Hrsg): Chronobiologie – Leopoldina-Symposium am 19. März 2010 in Halle (Saale)
por: Frings, Andreas
Publicado: (2012)

Outbreak of cryptosporidium hominis following river flooding in the city of Halle (Saale), Germany, August 2013
por: Gertler, Maximilian, et al.
Publicado: (2015)

SPACIA1/SAAL1: a newly identified gene associated with aberrant proliferation of synovial fibroblasts
por: Sato, Tomoo, et al.
Publicado: (2012)

Tumor immunology meets oncology (TIMO) XVI, July 07–09 2022 in Halle/Saale, Germany
por: Seliger, Barbara
Publicado: (2023)

Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma
por: Shen, J, et al.
Publicado: (2016)

Outpatient health care utilization and health expenditures of asylum seekers in Halle (Saale), Germany - an analysis of claims data
por: Niedermaier, Andreas, et al.
Publicado: (2020)

“Tumor immunology meets oncology (TIMO) XV”, April 25th–27th 2019, Halle/Saale, Germany
por: Steven, André, et al.
Publicado: (2020)

Integrin-Linked Kinase Overexpression and Its Oncogenic Role in Promoting Tumorigenicity of Hepatocellular Carcinoma
por: Chan, Jenny, et al.
Publicado: (2011)

Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma
por: Wang, Fang, et al.
Publicado: (2021)

Therapeutic and scintigraphic applications of polymeric micelles: combination of chemotherapy and radiotherapy in hepatocellular carcinoma
por: Shih, Ying-Hsia, et al.
Publicado: (2015)

Identification of WDR12 as a novel oncogene involved in hepatocellular carcinoma propagation
por: Yin, Yancun, et al.
Publicado: (2018)

Variant 2 of KIAA0101, antagonizing its oncogenic variant 1, might be a potential therapeutic strategy in hepatocellular carcinoma
por: Liu, Lijuan, et al.
Publicado: (2017)

Prognostic significance and oncogene function of cathepsin A in hepatocellular carcinoma
por: Wang, Huaxiang, et al.
Publicado: (2021)

Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma
por: Tao, Haisu, et al.
Publicado: (2022)

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

Integrated investigation and experimental validation of PPARG as an oncogenic driver: implications for prognostic assessment and therapeutic targeting in hepatocellular carcinoma
por: Ran, Yunsheng, et al.
Publicado: (2023)

IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway
por: Huang, Wei-Chieh, et al.
Publicado: (2018)

Pro-oncogenic potential of NM23-H2 in hepatocellular carcinoma
por: Lee, Mi-Jin, et al.
Publicado: (2012)

Usp5 functions as an oncogene for stimulating tumorigenesis in hepatocellular carcinoma
por: Liu, Yi, et al.
Publicado: (2017)

Die Impfaktion gegen Poliomyelitis in der DDR im Jahr 1960 am Beispiel der Stadt Halle (Saale): Historische Erfahrungen und Probleme
por: Wanke, Anne Thordis, et al.
Publicado: (2022)

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway
por: Huang, Wei-Chieh, et al.
Publicado: (2019)

Endogenous Retrotransposition Activates Oncogenic Pathways in Hepatocellular Carcinoma
por: Shukla, Ruchi, et al.
Publicado: (2013)

The oncogenic role of hepatitis delta virus in hepatocellular carcinoma
por: Puigvehí, Marc, et al.
Publicado: (2019)

The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma
por: Wu, Zhixian, et al.
Publicado: (2022)

Identification of Potentially Therapeutic Target Genes of Hepatocellular Carcinoma
por: Li, Chengzhang, et al.
Publicado: (2020)

MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma
por: You, Yu, et al.
Publicado: (2016)

Important oncogenic and immunogenic roles of SPP1 and CSF1 in hepatocellular carcinoma
por: Xiang, Tianxin, et al.
Publicado: (2023)

An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma
por: Chakraborty, Sayan, et al.
Publicado: (2015)

MAP7D3, a novel prognostic marker for triple-negative breast cancer, drives cell invasiveness and cancer-initiating cell properties to promote metastatic progression
por: Kuo, Wen-Hung, et al.
Publicado: (2023)

Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma
por: Li, Mei-Mei, et al.
Publicado: (2019)

Identification of Biological Targets of Therapeutic Intervention for Hepatocellular Carcinoma by Integrated Bioinformatical Analysis
por: Hu, Wei Qi, et al.
Publicado: (2018)

Transcriptomic analysis reveals the oncogenic role of S6K1 in hepatocellular carcinoma
por: Lai, Keng Po, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n86itj7e3efnhhdak19t3hrpgu